Filing Flows › Lyell Immunopharma (LYEL) › R&D spending
Lyell Immunopharma (LYEL) R&D spending by quarter
Lyell Immunopharma's R&D spending was $52.2M in Q4 2025 (fourth quarter 2025), +50% from Q2 2025. Over the last 3 quarters it ranged from $34.9M (Q2 2025) to $52.2M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $52.2M | +50% | — |
| Q2 2025 | $34.9M | -20% | — |
| Q1 2025 | $43.4M | — | — |
Q4 2025 at a glance
Lyell Immunopharma, Q4 2025: revenue $6K (-46% year over year), net loss $141M, operating cash flow −$32.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lyell Immunopharma's R&D spending?
Lyell Immunopharma's R&D spending was $52.2M in Q4 2025 (fourth quarter 2025), +50% from Q2 2025.
How has Lyell Immunopharma's R&D spending changed?
Over the last 3 quarters it ranged from $34.9M (Q2 2025) to $52.2M (Q4 2025).